Summit Tx Capital, L.P. Immunome Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Immunome Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 20,876 shares of IMNM stock, worth $170,348. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,876Holding current value
$170,348% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
149Shares Held
66.3MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$61.6 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$43.7 Million3.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.36MShares$35.6 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$35.1 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$33.3 Million2.16% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $99M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...